Vaccine-preventable diseases in Europe: where do we stand?
- PMID: 24958075
- DOI: 10.1586/14760584.2014.933077
Vaccine-preventable diseases in Europe: where do we stand?
Abstract
During the second half of the 20th century, vaccinations led to the control or even eradication of several vaccine-preventable diseases (VPDs) in Europe. However, outbreaks of VPDs continue to occur even in countries with well-established vaccination programs. Reasons include the existence of under-vaccinated populations, the increasing anti-vaccination movement and the increasing movement of populations across borders. Ensuring adequate levels of herd immunity is the only reliable method for preventing epidemics and a re-emergence of VPDs. In order to achieve this, more flexible vaccine delivery platforms are needed targeting the less-privileged people, especially in the context of the current economic crisis. Healthcare personnel and healthcare systems should be prepared to address these challenges in the following years.
Keywords: Europe; control; eradication; immunization; outbreaks; re-emergence; vaccination; vaccine-preventable diseases.
Similar articles
-
The spread of vaccine-preventable diseases by international travellers: a public-health concern.Clin Microbiol Infect. 2012 Oct;18 Suppl 5:77-84. doi: 10.1111/j.1469-0691.2012.03940.x. Epub 2012 Aug 6. Clin Microbiol Infect. 2012. PMID: 22862565 Review.
-
Strategies for decision-making on vaccine use: the French experience.Expert Rev Vaccines. 2015 Jul;14(7):917-22. doi: 10.1586/14760584.2015.1035650. Epub 2015 Apr 25. Expert Rev Vaccines. 2015. PMID: 25913015 Review.
-
Vaccination of healthcare workers: is mandatory vaccination needed?Expert Rev Vaccines. 2019 Jan;18(1):5-13. doi: 10.1080/14760584.2019.1552141. Epub 2018 Dec 10. Expert Rev Vaccines. 2019. PMID: 30501454 Review.
-
Immunosenescence: Implications for vaccination programmes in adults.Maturitas. 2011 Apr;68(4):322-30. doi: 10.1016/j.maturitas.2011.01.011. Epub 2011 Feb 12. Maturitas. 2011. PMID: 21316879 Review.
-
Promoting life course vaccination.Rejuvenation Res. 2011 Feb;14(1):75-81. doi: 10.1089/rej.2010.1078. Epub 2011 Jan 5. Rejuvenation Res. 2011. PMID: 21208066
Cited by
-
Measles among migrants in the European Union and the European Economic Area.Scand J Public Health. 2016 Feb;44(1):6-13. doi: 10.1177/1403494815610182. Epub 2015 Nov 12. Scand J Public Health. 2016. PMID: 26563254 Free PMC article. Review.
-
From population to public institutions: what needs to be changed to benefit from the full value of vaccination.J Mark Access Health Policy. 2015 Aug 12;3. doi: 10.3402/jmahp.v3.26965. eCollection 2015. J Mark Access Health Policy. 2015. PMID: 27123169 Free PMC article.
-
Challenges for nationwide vaccine delivery in African countries.Int J Health Econ Manag. 2018 Jun;18(2):197-219. doi: 10.1007/s10754-017-9229-5. Epub 2017 Oct 19. Int J Health Econ Manag. 2018. PMID: 29047019 Review.
-
National Immunization Therapeutic Advisory Group: it is time for experience sharing and best practice learning.J Mark Access Health Policy. 2015 Sep 14;3. doi: 10.3402/jmahp.v3.29276. eCollection 2015. J Mark Access Health Policy. 2015. PMID: 27123172 Free PMC article. No abstract available.
-
Adult vaccination as part of a healthy lifestyle: moving from medical intervention to health promotion.Ann Med. 2019 Mar;51(2):128-140. doi: 10.1080/07853890.2019.1588470. Epub 2019 Apr 26. Ann Med. 2019. PMID: 31025882 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical